{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0009111/OMIM:222748","label":"Dihydropyrimidinuria","mondoId":"MONDO:0009111","onsetQualifier":null,"recordKeys":["0a86ef4aeb9399d1dc36b2572fa93b451fd0e5d457c27f15205ddcade249a094","0c8a2122262aa4ff0454cc9a7690abdd2374414c8fc98d677fcc04d54c95685e","16e804be95c6b426c71470f40a4dd73cf06107a371f360439b763cf2d6ceaa30","1a4f17f4231327164ffda5bcfeceea82fd118d00a6ac91b725881a84edcc1431","239ba284c91b5520ad3be79cf5173e585b08d7a9e68fa34ab720eda4883f8620","2828ee00bb01b963661e9d77b8ce3066a2a8aad7ef874364df31b9bb5d63722d","351e7949d276ef93f48fafa9ce5d411affdb2a138f428dc01e004c2bc334092c","3f481356e8aee296fae50ccfbce6cfe6526a775e9034f8916beb90600a4eebdd","3f5639651dccb3e7832c1da4a6a9feb702e6a08f70cd47e729cd10ea12c7574c","449c6a9553bd4e6ee1dc1c98ab40a121cd3e0313dc250d9593ec5727ede856c5","452bdc1993909019dba38d281eb5f794fd477b70031d3db13d913d64e3cd1347","48737ca6aafda2acb5ab9b738fbfa4bf38fe209815034729102dbf43a66ffb2c","57b811ccda8a8244025cdd3c0f1434390dbbc74e9fd3de263e3f65bc2a0ac13f","61b19dab4049ab339b0fc7b79a3c2a09f0f644f962cecdc1d8a52e4375e35831","6f490a9a229d1a2d2f5d111c14405f9b52b21965ee4aa296db143f7a0bf68af9","870083ec27d15b1fc7948939c0c16f39897d58b89597fe762f4d5a0b5c4f4da6","88491a5d58dce15b5612e4b9d6a09c999088b9ff9f32b31df35d8c95d08e383d","8c6e99b0f20429cac4bc0f11aba7f870a3732167e0fb57c1edabfb6713cfba3f","8f1da4b3d9f7cdacbdf5c630fda20858733b9c302f65b19abafecc4772602e3c","96488d131e3c6dc958c15083f7eeb2608c0b4d2c8add35ad8fe45d9765958b77","99282c3f5cdda885ac9e877b9709a30235cd29b092de7330918d5888850fa4cd","9cdf2646ed7bd34f3fc6e59131692ebf9fd4cfdec0439d7fd75c9c597553d30d","9e3f71b1dd153773ccd309d7af0ec01057065068ecaa522e513e6cbf65f682d7","a17482cabd20003b59e32c824fa4cd42ba46b402a6d2dda0c4e5a4e20158ab9c","a55c7f7891a66e98dbcd819da613a1868cc5a3c6c598970f38b3afa755851464","a655d5171a242e80f0c6bc061c662fa1adc892c0a461d4cb5eeada60bd91674b","a9c618c2e72b45226cbdd2780f5acbe489b60b000245690d47855eeac5bec258","b0501fbbd3584f9f3eddb075f4b2be7d4248c4c1bd684a18f1b906ff6347c5d5","bd38f1a13edbec7f4943acfe7ec53884a1635272f6b25c53fe0c440925eb57fb","bf4dd4a2ab7a914837cd61d9955d6b900eb4787eb5c8d855aca8af1f716e781c","c76da6331e00cb72872831378732bb67fe2c04c2f94ee4b7488d61db4f136b7b","e0cac9c0560751cba4262108e3c4eb0d2989b7c372449924d179a9ac06c4a92c","e4f4fba07ce470e12c7f67872b463b5894b164c402a6705a2634c12cff27be4c","f615c347ca079444dcee03f53edb5032c8caf57480e4b4d32e099ed806f70a07","fca1943b9c1eb4ffa2c4e95c4ee410b3f20d622e11ad213945ce9c325590db02"],"recordQualifiers":{},"scopeLabel":"OMIM:222748","sourceIds":["OMIM:222748"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"MONDO:0009111/ORPHA:38874","label":"Dihydropyrimidinuria","mondoId":"MONDO:0009111","onsetQualifier":null,"recordKeys":["00891bab2368b0a7eececa79a4e9a4aa5949323bd5b280733ba4649b8383e7dd","1621964e90551d59e748b61d20583b75c37c975359eb5ee1865d249998e62765","1623944670dd33dedd066f3b9c98bbe022b5204b0e303f7f24b40970e60c890e","29270bf387986521c29aebb448095240476c55a17cbd5fd16bdb835302a925a2","32d42058385255ab18dd78730efe4e0adc04d89fb486785780b6c78cba4ab0f1","3adc18ddf6139319683660fd2cb55ff6792e6316981365fc163f11878499db4a","4ee2c7c78333c585a2dd0935c817519f60f987d8d75a03dcfab7b3072ce6247e","513560259a1bd8d62a4b64f63d1bbf7220fcd2056906787a1e7076be6396e09c","5d274b669056402a9f460487bcce100b00552c4bc05ff3f8f79a0b1f2f44dfd4","748e36e9359c5a07d0de05938bfc24656c6eb8e41648e39baed97a23b9e0c5c5","84700174cbb7a87e749a8f608c7d01b41362d9c81b129930ab71842d3e6bfdef","85b2ce52ee79613ed8fc07eb12948e28811aefab24f1cfb395f27673dc0920a6","8b2d974f180ce3a548b9525cbf0979d88fd739d3d62007ad397444dfbbdb5da1","b77a20718b210b785a517efd7a3d53f90322a2cfdaffa2fd75111066769c5118","b940e83b5e63bad7b6b704a4060489edd6ccdaa8dc7f30d1683321ae7c8bb6b6","d2390b8cfa5d87f4d679e62607a53dcb2fe9c465a5272978ac84699261751f71","d8c41ff071cad7956a4e45014fc0395856113ad82aee101ba2bb6874e2c06d45","ec3c5cdfff6ac13912d293cb503ff782706e0bc8c900605490474fad8a07b826","f1b185d70d67546a1caf354a1f0a10933f29fbb2207293698c15731eed92eee7","fd4070232f075ddb78d90f814033d59d71aaaaa5580c3a799c5556375db2b0fc"],"recordQualifiers":{},"scopeLabel":"ORPHA:38874","sourceIds":["ORPHA:38874"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0009111/OMIM:222748","MONDO:0009111/ORPHA:38874"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"

Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.

"},"coverage":{"countRecords":21,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":55,"sourceGroups":{"omim":13,"orphanet":20,"published":22}},"features":[{"hpoId":"HP:0002500","label":"Abnormal cerebral white matter morphology","primary":false},{"hpoId":"HP:0007256","label":"Abnormal pyramidal sign","primary":false},{"hpoId":"HP:0002062","label":"Abnormal pyramidal tract morphology","primary":false},{"hpoId":"HP:0002023","label":"Anal atresia","primary":false},{"hpoId":"HP:0007018","label":"Attention deficit hyperactivity disorder","primary":false},{"hpoId":"HP:0000717","label":"Autism","primary":false},{"hpoId":"HP:0000280","label":"Coarse facial features","primary":false},{"hpoId":"HP:0000750","label":"Delayed speech and language","primary":false},{"hpoId":"HP:0002376","label":"Developmental regression","primary":false},{"hpoId":"HP:0031964","label":"Elevated circulating alanine aminotransferase concentration","primary":false},{"hpoId":"HP:0012544","label":"Elevated circulating aldolase concentration","primary":false},{"hpoId":"HP:0031956","label":"Elevated circulating aspartate aminotransferase concentration","primary":false},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":false},{"hpoId":"HP:0034593","label":"Elevated circulating dihydrouracil concentration","primary":false},{"hpoId":"HP:4000095","label":"Elevated circulating thymine concentration","primary":false},{"hpoId":"HP:0033139","label":"Elevated circulating uracil concentration","primary":false},{"hpoId":"HP:6000211","label":"Elevated CSF dihydrouracil concentration","primary":false},{"hpoId":"HP:6000119","label":"Elevated urinary dihydrothymine level","primary":false},{"hpoId":"HP:6000118","label":"Elevated urinary dihydrouracil level","primary":false},{"hpoId":"HP:6000331","label":"Elevated urinary thymine level","primary":false},{"hpoId":"HP:0001262","label":"Excessive daytime somnolence","primary":false},{"hpoId":"HP:0003710","label":"Exercise-induced muscle cramps","primary":false},{"hpoId":"HP:0007308","label":"Extrapyramidal dyskinesia","primary":false},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":false},{"hpoId":"HP:0011968","label":"Feeding difficulties","primary":false},{"hpoId":"HP:0002020","label":"Gastroesophageal reflux","primary":false},{"hpoId":"HP:0001510","label":"Growth delay","primary":false},{"hpoId":"HP:0000752","label":"Hyperactivity","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0001254","label":"Lethargy","primary":false},{"hpoId":"HP:0000256","label":"Macrocephaly","primary":false},{"hpoId":"HP:0001942","label":"Metabolic acidosis","primary":false},{"hpoId":"HP:0000252","label":"Microcephaly","primary":false},{"hpoId":"HP:0012758","label":"Neurodevelopmental delay","primary":false},{"hpoId":"HP:0001357","label":"Plagiocephaly","primary":false},{"hpoId":"HP:0003654","label":"Reduced dihydropyrimidine dehydrogenase level","primary":false},{"hpoId":"HP:6000083","label":"Reduced hepatic dihydropyrimidinase activity","primary":false},{"hpoId":"HP:0001250","label":"Seizures","primary":false},{"hpoId":"HP:0009803","label":"Short phalanx of finger","primary":false},{"hpoId":"HP:0001762","label":"Talipes equinovarus","primary":false},{"hpoId":"HP:0012127","label":"Uraciluria","primary":false},{"hpoId":"HP:0011473","label":"Villous atrophy","primary":false},{"hpoId":"HP:0002013","label":"Vomiting","primary":false}],"ledeHtml":"Dihydropyrimidinase deficiency is a disorder that can cause neurological and gastrointestinal problems in some affected individuals. Other people with dihydropyrimidinase deficiency have no signs or symptoms related to the disorder, and in these individuals the condition can be diagnosed only by laboratory testing.","mondoId":"MONDO:0009111","records":[{"frequencyKind":"range","key":"00891bab2368b0a7eececa79a4e9a4aa5949323bd5b280733ba4649b8383e7dd","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:38874","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011473","is_excluded":false,"label":"Villous atrophy","onset_id":null,"reference":"ORPHA:38874","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"0a86ef4aeb9399d1dc36b2572fa93b451fd0e5d457c27f15205ddcade249a094","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001262","is_excluded":false,"label":"Excessive daytime somnolence","onset_id":null,"reference":"OMIM:222748","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"0c8a2122262aa4ff0454cc9a7690abdd2374414c8fc98d677fcc04d54c95685e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:4000095","is_excluded":false,"label":"Elevated circulating thymine concentration","onset_id":null,"reference":"PMID:17383919","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"1621964e90551d59e748b61d20583b75c37c975359eb5ee1865d249998e62765","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:38874","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:6000331","is_excluded":false,"label":"Elevated urinary thymine level","onset_id":null,"reference":"ORPHA:38874","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1623944670dd33dedd066f3b9c98bbe022b5204b0e303f7f24b40970e60c890e","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:38874","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000280","is_excluded":false,"label":"Coarse facial features","onset_id":null,"reference":"ORPHA:38874","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"16e804be95c6b426c71470f40a4dd73cf06107a371f360439b763cf2d6ceaa30","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0031964","is_excluded":false,"label":"Elevated circulating alanine aminotransferase concentration","onset_id":null,"reference":"PMID:30384990","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"1a4f17f4231327164ffda5bcfeceea82fd118d00a6ac91b725881a84edcc1431","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:6000118","is_excluded":false,"label":"Elevated urinary dihydrouracil level","onset_id":null,"reference":"PMID:30384990","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"239ba284c91b5520ad3be79cf5173e585b08d7a9e68fa34ab720eda4883f8620","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002023","is_excluded":false,"label":"Anal atresia","onset_id":null,"reference":"OMIM:222748","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"2828ee00bb01b963661e9d77b8ce3066a2a8aad7ef874364df31b9bb5d63722d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007256","is_excluded":false,"label":"Abnormal pyramidal sign","onset_id":null,"reference":"OMIM:222748","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"29270bf387986521c29aebb448095240476c55a17cbd5fd16bdb835302a925a2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:38874","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000252","is_excluded":false,"label":"Microcephaly","onset_id":null,"reference":"ORPHA:38874","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"32d42058385255ab18dd78730efe4e0adc04d89fb486785780b6c78cba4ab0f1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:38874","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"ORPHA:38874","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"351e7949d276ef93f48fafa9ce5d411affdb2a138f428dc01e004c2bc334092c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002500","is_excluded":false,"label":"Abnormal cerebral white matter morphology","onset_id":null,"reference":"OMIM:222748","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"3adc18ddf6139319683660fd2cb55ff6792e6316981365fc163f11878499db4a","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:38874","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"ORPHA:38874","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"3f481356e8aee296fae50ccfbce6cfe6526a775e9034f8916beb90600a4eebdd","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0000750","is_excluded":false,"label":"Delayed speech and language development","onset_id":null,"reference":"PMID:17383919","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"3f5639651dccb3e7832c1da4a6a9feb702e6a08f70cd47e729cd10ea12c7574c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001942","is_excluded":false,"label":"Metabolic acidosis","onset_id":null,"reference":"OMIM:222748","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"449c6a9553bd4e6ee1dc1c98ab40a121cd3e0313dc250d9593ec5727ede856c5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0007308","is_excluded":false,"label":"Extrapyramidal dyskinesia","onset_id":null,"reference":"OMIM:222748","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"452bdc1993909019dba38d281eb5f794fd477b70031d3db13d913d64e3cd1347","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:6000119","is_excluded":false,"label":"Elevated urinary dihydrothymine level","onset_id":null,"reference":"PMID:30384990","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"48737ca6aafda2acb5ab9b738fbfa4bf38fe209815034729102dbf43a66ffb2c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":"3/20","hpo_id":"HP:0000717","is_excluded":false,"label":"Autism","onset_id":null,"reference":"PMID:20362666","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"4ee2c7c78333c585a2dd0935c817519f60f987d8d75a03dcfab7b3072ce6247e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:38874","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:6000119","is_excluded":false,"label":"Elevated urinary dihydrothymine level","onset_id":null,"reference":"ORPHA:38874","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"513560259a1bd8d62a4b64f63d1bbf7220fcd2056906787a1e7076be6396e09c","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:38874","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"ORPHA:38874","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"57b811ccda8a8244025cdd3c0f1434390dbbc74e9fd3de263e3f65bc2a0ac13f","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0033139","is_excluded":false,"label":"Elevated circulating uracil concentration","onset_id":null,"reference":"PMID:17383919","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"5d274b669056402a9f460487bcce100b00552c4bc05ff3f8f79a0b1f2f44dfd4","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:38874","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000256","is_excluded":false,"label":"Macrocephaly","onset_id":null,"reference":"ORPHA:38874","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"61b19dab4049ab339b0fc7b79a3c2a09f0f644f962cecdc1d8a52e4375e35831","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0003654","is_excluded":false,"label":"Reduced dihydropyrimidine dehydrogenase level","onset_id":null,"reference":"PMID:17383919","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"6f490a9a229d1a2d2f5d111c14405f9b52b21965ee4aa296db143f7a0bf68af9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002062","is_excluded":false,"label":"Abnormal pyramidal tract morphology","onset_id":null,"reference":"OMIM:222748","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"748e36e9359c5a07d0de05938bfc24656c6eb8e41648e39baed97a23b9e0c5c5","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:38874","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002013","is_excluded":false,"label":"Vomiting","onset_id":null,"reference":"ORPHA:38874","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"84700174cbb7a87e749a8f608c7d01b41362d9c81b129930ab71842d3e6bfdef","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:38874","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000717","is_excluded":false,"label":"Autism","onset_id":null,"reference":"ORPHA:38874","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"85b2ce52ee79613ed8fc07eb12948e28811aefab24f1cfb395f27673dc0920a6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:38874","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:38874","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"870083ec27d15b1fc7948939c0c16f39897d58b89597fe762f4d5a0b5c4f4da6","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":"4/20","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"PMID:20362666","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"88491a5d58dce15b5612e4b9d6a09c999088b9ff9f32b31df35d8c95d08e383d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0031956","is_excluded":false,"label":"Elevated circulating aspartate aminotransferase concentration","onset_id":null,"reference":"PMID:30384990","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"8b2d974f180ce3a548b9525cbf0979d88fd739d3d62007ad397444dfbbdb5da1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:38874","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0002376","is_excluded":false,"label":"Developmental regression","onset_id":null,"reference":"ORPHA:38874","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"8c6e99b0f20429cac4bc0f11aba7f870a3732167e0fb57c1edabfb6713cfba3f","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0012127","is_excluded":false,"label":"Uraciluria","onset_id":null,"reference":"PMID:17383919","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"8f1da4b3d9f7cdacbdf5c630fda20858733b9c302f65b19abafecc4772602e3c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000752","is_excluded":false,"label":"Hyperactivity","onset_id":null,"reference":"PMID:30384990","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"96488d131e3c6dc958c15083f7eeb2608c0b4d2c8add35ad8fe45d9765958b77","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":"6/20","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"PMID:20362666","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"99282c3f5cdda885ac9e877b9709a30235cd29b092de7330918d5888850fa4cd","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":"12/19","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"PMID:20362666","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"9cdf2646ed7bd34f3fc6e59131692ebf9fd4cfdec0439d7fd75c9c597553d30d","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0009803","is_excluded":false,"label":"Short phalanx of finger","onset_id":null,"reference":"OMIM:222748","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"9e3f71b1dd153773ccd309d7af0ec01057065068ecaa522e513e6cbf65f682d7","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":"7/20","hpo_id":"HP:0011968","is_excluded":false,"label":"Feeding difficulties","onset_id":null,"reference":"PMID:20362666","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"a17482cabd20003b59e32c824fa4cd42ba46b402a6d2dda0c4e5a4e20158ab9c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:6000331","is_excluded":false,"label":"Elevated urinary thymine level","onset_id":null,"reference":"PMID:20362666","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"a55c7f7891a66e98dbcd819da613a1868cc5a3c6c598970f38b3afa755851464","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001762","is_excluded":false,"label":"Talipes equinovarus","onset_id":null,"reference":"OMIM:222748","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"a655d5171a242e80f0c6bc061c662fa1adc892c0a461d4cb5eeada60bd91674b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"PMID:30384990","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"a9c618c2e72b45226cbdd2780f5acbe489b60b000245690d47855eeac5bec258","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001254","is_excluded":false,"label":"Lethargy","onset_id":null,"reference":"OMIM:222748","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"b0501fbbd3584f9f3eddb075f4b2be7d4248c4c1bd684a18f1b906ff6347c5d5","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0012544","is_excluded":false,"label":"Elevated circulating aldolase concentration","onset_id":null,"reference":"PMID:30384990","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"b77a20718b210b785a517efd7a3d53f90322a2cfdaffa2fd75111066769c5118","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:38874","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012127","is_excluded":false,"label":"Uraciluria","onset_id":null,"reference":"ORPHA:38874","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b940e83b5e63bad7b6b704a4060489edd6ccdaa8dc7f30d1683321ae7c8bb6b6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:38874","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007018","is_excluded":false,"label":"Attention deficit hyperactivity disorder","onset_id":null,"reference":"ORPHA:38874","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"bd38f1a13edbec7f4943acfe7ec53884a1635272f6b25c53fe0c440925eb57fb","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001357","is_excluded":false,"label":"Plagiocephaly","onset_id":null,"reference":"OMIM:222748","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"bf4dd4a2ab7a914837cd61d9955d6b900eb4787eb5c8d855aca8af1f716e781c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0034593","is_excluded":false,"label":"Elevated circulating dihydrouracil concentration","onset_id":null,"reference":"OMIM:222748","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"c76da6331e00cb72872831378732bb67fe2c04c2f94ee4b7488d61db4f136b7b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":"3/20","hpo_id":"HP:0000252","is_excluded":false,"label":"Microcephaly","onset_id":null,"reference":"PMID:20362666","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"d2390b8cfa5d87f4d679e62607a53dcb2fe9c465a5272978ac84699261751f71","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:38874","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001510","is_excluded":false,"label":"Growth delay","onset_id":null,"reference":"ORPHA:38874","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d8c41ff071cad7956a4e45014fc0395856113ad82aee101ba2bb6874e2c06d45","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:38874","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002020","is_excluded":false,"label":"Gastroesophageal reflux","onset_id":null,"reference":"ORPHA:38874","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"e0cac9c0560751cba4262108e3c4eb0d2989b7c372449924d179a9ac06c4a92c","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0003710","is_excluded":false,"label":"Exercise-induced muscle cramps","onset_id":null,"reference":"PMID:30384990","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"e4f4fba07ce470e12c7f67872b463b5894b164c402a6705a2634c12cff27be4c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:6000083","is_excluded":false,"label":"Reduced hepatic dihydropyrimidinase activity","onset_id":null,"reference":"OMIM:222748","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"ec3c5cdfff6ac13912d293cb503ff782706e0bc8c900605490474fad8a07b826","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:38874","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:6000118","is_excluded":false,"label":"Elevated urinary dihydrouracil level","onset_id":null,"reference":"ORPHA:38874","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f1b185d70d67546a1caf354a1f0a10933f29fbb2207293698c15731eed92eee7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:38874","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012758","is_excluded":false,"label":"Neurodevelopmental delay","onset_id":null,"reference":"ORPHA:38874","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"f615c347ca079444dcee03f53edb5032c8caf57480e4b4d32e099ed806f70a07","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":"4/20","hpo_id":"HP:0001510","is_excluded":false,"label":"Growth delay","onset_id":null,"reference":"PMID:20362666","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"fca1943b9c1eb4ffa2c4e95c4ee410b3f20d622e11ad213945ce9c325590db02","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:222748","disease_name":"Dihydropyrimidinuria","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:6000211","is_excluded":false,"label":"Elevated CSF dihydrouracil concentration","onset_id":null,"reference":"PMID:6467612","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"fd4070232f075ddb78d90f814033d59d71aaaaa5580c3a799c5556375db2b0fc","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:38874","disease_name":"Dihydropyrimidinuria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011968","is_excluded":false,"label":"Feeding difficulties","onset_id":null,"reference":"ORPHA:38874","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"","identityNote":"MONDO cross-references identify native condition entries. Ancestor membership does not transfer phenotype values between groups.","importantHtml":""},"sections":[{"bodyHtml":"

Dihydropyrimidinase deficiency is caused by mutations in the DPYS gene, which provides instructions for making an enzyme called dihydropyrimidinase. This enzyme is involved in the breakdown of molecules called pyrimidines, which are building blocks of DNA and its chemical cousin RNA. The dihydropyrimidinase enzyme is involved in the second step of the three-step process that breaks down pyrimidines. This step opens the ring-like structures of molecules called 5,6-dihydrothymine and 5,6-dihydrouracil so that these molecules can be further broken down.

The DPYS gene mutations that cause dihydropyrimidinase deficiency greatly reduce or eliminate dihydropyrimidinase enzyme function. As a result, the enzyme is unable to begin the breakdown of 5,6-dihydrothymine and 5,6-dihydrouracil. Excessive amounts of these molecules accumulate in the blood and in the fluid that surrounds and protects the brain and spinal cord (the cerebrospinal fluid or CSF) and are released in the urine.

The relationship between the inability to break down 5,6-dihydrothymine and 5,6-dihydrouracil and the specific features of dihydropyrimidinase deficiency is unclear. Failure to complete this step in the breakdown of pyrimidines also impedes the final step of the process, which produces molecules called beta-aminoisobutyric acid and beta-alanine. Both of these molecules are thought to protect the nervous system and help it function properly. Reduced production of beta-aminoisobutyric acid and beta-alanine may impair the function of these molecules in the nervous system, leading to neurological problems in some people with dihydropyrimidinase deficiency. Because fluoropyrimidine drugs are broken down by the same three-step process as pyrimidines, deficiency of the dihydropyrimidinase enzyme could lead to the drug buildup that causes fluoropyrimidine toxicity.

It is unknown why some people with dihydropyrimidinase deficiency do not develop health problems related to the condition; other genetic and environmental factors likely help determine the effects of this disorder.

MedlinePlus Genetics: Causes

","key":"forms","title":"What causes Dihydropyrimidinase deficiency?"},{"bodyHtml":"

The neurological abnormalities that occur most often in people with dihydropyrimidinase deficiency are intellectual disability, seizures, and weak muscle tone (hypotonia). An abnormally small head size (microcephaly) and autistic behaviors that affect communication and social interaction also occur in some individuals with this condition.

Gastrointestinal problems that occur in dihydropyrimidinase deficiency include backflow of acidic stomach contents into the esophagus (gastroesophageal reflux) and recurrent episodes of vomiting (cyclic vomiting). Affected individuals can also have deterioration (atrophy) of the small, finger-like projections (villi) that line the small intestine and provide a large surface area with which to absorb nutrients. This condition, called villous atrophy, can lead to difficulty absorbing nutrients from foods (malabsorption), resulting in a failure to grow and gain weight at the expected rate (failure to thrive).

People with dihydropyrimidinase deficiency, including those who otherwise exhibit no symptoms, may be vulnerable to severe, potentially life-threatening toxic reactions to certain drugs called fluoropyrimidines that are used to treat cancer. Common examples of these drugs are 5-fluorouracil and capecitabine. These drugs may not be broken down efficiently and can build up to toxic levels in the body (fluoropyrimidine toxicity), leading to drug reactions including gastrointestinal problems, blood abnormalities, and other signs and symptoms.

Source: MedlinePlus Genetics

","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"dihydropyrimidinase-deficiency","sourceDocuments":[{"name":"Dihydropyrimidinase deficiency","reviewed":"2014-09","sections":{"causes":{"fetchedAt":"2026-10-20T20:20:58.137663+00:00","label":"Causes","pageSha256":"7596c7f1432017e4af916ac667a263effe063b5162d45adc833b9ee0c692e54d","sourceUrl":"https://medlineplus.gov/genetics/condition/dihydropyrimidinase-deficiency/#causes","status":"available"}},"source_release":"2026-10-01","url":"https://medlineplus.gov/genetics/condition/dihydropyrimidinase-deficiency"}],"sourceNote":"MedlinePlus descriptions and Causes; original HPO annotations.","takeawayHtml":"Cause explanations are from MedlinePlus Genetics. Feature values below retain their original sources and patient groups.","title":"Dihydropyrimidinase deficiency"},"schemaVersion":1}